SCHEMBL83966

SCHEMBL83966

CN1C(=O)COCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12898202 0.82
SCHEMBL12360493 0.81 POLB (0.33)
SCHEMBL6200536 0.73 GSK3A (0.33)
SCHEMBL261177 0.71
SCHEMBL11930001 0.71 POLB (0.31)
SCHEMBL5455984 0.71
SCHEMBL186442 0.71
SCHEMBL23894741 0.69 GSK3A (0.38)
SCHEMBL27941 0.69
SCHEMBL9020270 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4072583-A Electrolytic carboxylation of carbon acids via electrogenerated bases MONSANTO COMPANY (US) 1978-02-07 US claimed
EP-2978820-B1 WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES NITTO DENKO CORP (JP) 2018-03-21 EP disclosed
EP-2788450-B1 WAVELENGTH CONVERSION MATERIAL AS ENCAPSULANT FOR SOLAR MODULE SYSTEMS TO ENHANCE SOLAR HARVESTING EFFICIENCY NITTO DENKO CORP (JP) 2017-06-21 EP disclosed
WO-2017093545-A1 ANTI-BACTERIAL COMPOUNDS BASED ON AMINO-GOLD PHOSPHINE COMPLEXES AUSPHERIX LIMITED (GB) 2017-06-08 WO disclosed
US-20170049781-A1 HSP90 INHIBITOR COMBINATIONS NOVARTIS AG (CH) 2017-02-23 US disclosed
US-20170049781-A1 HSP90 INHIBITOR COMBINATIONS NOVARTIS AG (CH) 2017-02-23 US disclosed
US-20160346292-A1 PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR NOVARTIS AG (CH) 2016-12-01 US disclosed
US-20160346292-A1 PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR NOVARTIS AG (CH) 2016-12-01 US disclosed
US-20160288057-A1 NANOFILTRATION MEMBRANES AND METHODS OF USE NOVOMER, INC. (US) 2016-10-06 US disclosed
US-20160288057-A1 NANOFILTRATION MEMBRANES AND METHODS OF USE NOVOMER, INC. (US) 2016-10-06 US disclosed
WO-2007041362-A1 2-AMINO-7,8-DIHYDRO-6H-PYRIDO[4,3-D] PYRIMIDIN-5-ONES NOVARTIS AG (CH) 2007-04-12 WO disclosed
EP-1473330-B1 Process for the synthesis of oxonol compound FUJI PHOTO FILM CO LTD (JP) 2007-02-14 EP disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070010531-A1 Substituted pyrazole compounds MERCK PATENT GMBH (DE) 2007-01-11 US disclosed
US-20070010531-A1 Substituted pyrazole compounds MERCK PATENT GMBH (DE) 2007-01-11 US disclosed
US-4132611-A Addition of organic electrophiles to carbon acids via catalysis by electrogenerated bases MONSANTO COMPANY (US) 1979-01-02 US disclosed
US-4130711-A DEHYDROGENATION OF A N-HYDROXYALKYL N-AMIDOALKYL AMINE, REDUCED COPPER CATALYST THE DOW CHEMICAL COMPANY (US) 1978-12-19 US disclosed
US-4082748-A CATALYTIC DEHYDROCYCLIZATION THE DOW CHEMICAL COMPANY (US) 1978-04-04 US disclosed
US-4072583-A Electrolytic carboxylation of carbon acids via electrogenerated bases MONSANTO COMPANY (US) 1978-02-07 US disclosed